MSL
IONS icon

Mackay Shields LLC’s Ionis Pharmaceuticals IONS Stock Holding History

Mackay Shields LLC’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-17,220
Closed -$1.11M – 1454
2019
Q2 		$1.11M Sell
17,220
-23,601
-58% -$1.67M 0.01% 1096
2019
Q1 		$3.31M Buy
40,821
+7,200
+21% +$464K 0.02% 586
2018
Q4 		$1.82M Buy
+33,621
New +$1.71M 0.01% 700

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Mackay Shields LLC's IONS Position: Q3 2019 in Review

Mackay Shields LLC sold out of Ionis Pharmaceuticals (IONS) in Q3 2019, closing a stake of 17,220 shares — an estimated $1.11M sold.

Mackay Shields LLC first reported a position in IONS in Q4 2018 and held it in 3 quarters. The position peaked at $3.31M in Q1 2019. 369 funds tracked by Wall St. Rank hold IONS as of Q3 2019.

  • Mackay Shields LLC reported no remaining Ionis Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Mackay Shields LLC sold 17,220 Ionis Pharmaceuticals shares in Q3 2019, an estimated $1.11M.
  • Mackay Shields LLC first reported a position in Ionis Pharmaceuticals in Q4 2018 and held it in 3 quarters.
  • Mackay Shields LLC's Ionis Pharmaceuticals position peaked at $3.31M in Q1 2019.
  • 369 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2019.

Based on Mackay Shields LLC's 13F filing for Q3 2019, filed 1 Nov 2019.